Testing effectiveness (Phase 2)Study completedNCT03389308
What this trial is testing
Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa Simplex
Castle Creek Pharmaceuticals, LLC 51